While less than half of large employers currently cover the new generation of obesity drugs, an additional 18% say they're considering adding them amid surging interest, according to findings from Mercer.

Artificial intelligence could reduce clinicians' administrative work and accelerate drug innovation, but the new technology needs oversight, said lawmakers, who met last week to discuss benefits as well as possible threats of AI.

Benefits such as emergency savings accounts and student loan repayment are each offered in only about 5-10% of companies today, however, the new legislation paves the way for real progress to increase savings for more workers.

More than one-third of companies are disclosing individual pay ranges to employees, and an even larger number (46%) are planning or considering doing so in the future.